Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Two Lanterns Venture Partners is a private venture capital firm focused on pre-seed and seed investments in early-stage software startups. The firm primarily invests in AI-native and AI-empowered companies in the United States and Israel, rather than operating as a drug developer, healthcare company, or life sciences platform business. It was founded by John Harthorne, former CEO and founder of MassChallenge, and positions itself around backing high-impact founders at the earliest stages. While some third-party sources mention exposure to healthcare or healthtech investments, the firm's own positioning is centered on software venture investing rather than biotech, pharma, or clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Two Lanterns Venture Partners.